In accordance with these studies, we also discovered that HNRNPA2B1 was upregulated in NSCLC tissue samples and associated with distant metastasis and unfavorable overall survival in patients with NSCLC, implying that HNRNPA2B1 might be a prognostic factor for poor survival in NSCLC. This evidence concerns the gene HNRNPA2B1 and non-small cell lung carcinoma.